What is it about?
Parkinson's disease and dementia with Lewy bodies are neurodegenerative diseases that involve a buildup of protein aggregates in the brain. The method described here provides a way to measure and understand how these aggregates interact with other molecules in the brain.
Photo by Hal Gatewood on Unsplash
Why is it important?
The method may help understand the fundamental molecular features of the neurodegenerative disease process.
Read the Original
This page is a summary of: In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain, Proceedings of the National Academy of Sciences, January 2022, Proceedings of the National Academy of Sciences,
You can read the full text:
The following have contributed to this page